Literature DB >> 25956231

Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.

Ming-Jen Lee1, Ya-Fang Chen2, Pi-Chuan Fan3, Kuo-Chuan Wang4, Kai Wang5, Jinyuan Wang6, Meng-Fai Kuo7.   

Abstract

Moyamoya disease (MMD) is a disorder characterized by stenosis of bilateral internal carotid arteries with compensatory angiogenesis of the perforating blood vessels. Familial transmission in MMD is common. Recently, mutations in human RNF213 and ACTA2 genes were identified to be responsible for MMD. The present study was to determine whether Taiwanese MMD patients carried mutations in these two genes. Of the 36 MMD patients, eleven was found to have RNF213 mutations. Direct genetic sequencing identified four different RNF213 mutations in the 11 patients from 8 families: five with a p.R4810K, one with p.A1622V, one with p.V3933M, and the other one with p.R4131C. The latter three represent novel missense mutations. No mutation in ACTA2 gene was identified. Clinically, cerebral infarction was common in patients with an RNF213 mutation (9/11). In addition, four mutant patients had developmental delay (4/11) and two had mental dysfunction (2/11). The magnetic resonance angiography of asymptomatic mutant carriers demonstrated high incidence of multiple stenosis of intracranial vessels (3/6, 50%). Since 30.6% (11/36) of Taiwanese moyamoya patients carry an RNF213 mutation and intracranial arterial stenosis was found in half of the asymptomatic mutant carriers, it is suggested that the RNF213 mutation should form part of the diagnostic workup for MMD in clinical practice.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACTA2; ICA stenosis; Moyamoya disease; Mutation frequency; RNF213; Taiwan

Mesh:

Substances:

Year:  2015        PMID: 25956231     DOI: 10.1016/j.jns.2015.04.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.

Authors:  Stéphanie Guey; Markus Kraemer; Dominique Hervé; Thomas Ludwig; Manoëlle Kossorotoff; Françoise Bergametti; Jan Claudius Schwitalla; Simone Choi; Lucile Broseus; Isabelle Callebaut; Emmanuelle Genin; Elisabeth Tournier-Lasserve
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

2.  RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population.

Authors:  Sirui Zhou; Amirthagowri Ambalavanan; Daniel Rochefort; Pingxing Xie; Cynthia V Bourassa; Pascale Hince; Alexandre Dionne-Laporte; Dan Spiegelman; Ziv Gan-Or; Cathy Mirarchi; Vessela Zaharieva; Nicolas Dupré; Hatasu Kobayashi; Toshiaki Hitomi; Kouji Harada; Akio Koizumi; Lan Xiong; Patrick A Dion; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

Review 3.  Role of Ring Finger Protein 213 in Moyamoya Disease.

Authors:  Yong-Gang Ma; Qian Zhang; Le-Bao Yu; Ji-Zong Zhao
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

4.  Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.

Authors:  Mi-Ae Jang; Jong-Won Chung; Je Young Yeon; Jong-Soo Kim; Seung Chyul Hong; Oh Young Bang; Chang-Seok Ki
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

Review 5.  Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.

Authors:  Xin Liao; Jing Deng; Wenjie Dai; Tong Zhang; Junxia Yan
Journal:  Environ Health Prev Med       Date:  2017-11-02       Impact factor: 3.674

6.  Rare RNF213 variants and the risk of intracranial artery stenosis/occlusion disease in Chinese population: a case-control study.

Authors:  Xin Liao; Tong Zhang; Bingyang Li; Shimin Hu; Junyu Liu; Jing Deng; Hongzhuan Tan; Junxia Yan
Journal:  BMC Med Genet       Date:  2019-03-29       Impact factor: 2.103

7.  The Impact of Moyamoya Disease and RNF213 Mutations on the Spectrum of Plasma Protein and MicroRNA.

Authors:  Ming-Jen Lee; Shannon Fallen; Yong Zhou; David Baxter; Kelsey Scherler; Meng-Fai Kuo; Kai Wang
Journal:  J Clin Med       Date:  2019-10-10       Impact factor: 4.241

8.  Novel missense variants in the RNF213 gene from a European family with Moyamoya disease.

Authors:  Andrey N Gagunashvili; Louise Ocaka; Daniel Kelberman; Pinki Munot; Chiara Bacchelli; Philip L Beales; Vijeya Ganesan
Journal:  Hum Genome Var       Date:  2019-08-08

Review 9.  A new horizon of moyamoya disease and associated health risks explored through RNF213.

Authors:  Akio Koizumi; Hatasu Kobayashi; Toshiaki Hitomi; Kouji H Harada; Toshiyuki Habu; Shohab Youssefian
Journal:  Environ Health Prev Med       Date:  2015-12-10       Impact factor: 3.674

Review 10.  α-Smooth Muscle Actin and ACTA2 Gene Expressions in Vasculopathies.

Authors:  Shi-Min Yuan
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.